Helena Angel-Scott

Helena Angel-Scott

Auto-generated profile, based on publicly available information

Helena Angel-Scott

Discipline of Psychiatry & Mental Health, University of New South Wales, Sydney, NSW, Australia

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 May 2019 in PLOS Biology
Verified
Journal Article
Open access
PDF file
GCGillian L Currie
Gillian L Currie
HAHelena N Angel-Scott
Helena N Angel-Scott
LCLesley Colvin
Lesley Colvin
FCFala Cramond
Fala Cramond
KHKaitlyn Hair
Kaitlyn Hair
ESEmily S Sena
Emily S Sena
We report a systematic review and meta-analysis of research using animal models of chemotherapy-induced peripheral neuropathy (CIPN). We systematically searched 5 online databases in September 2012 and updated the search in November 2015 using machine learning and text mining to reduce the screening for inclusion workload and improve accuracy. For each comparison, we calculated a standardised mean difference (SMD) effect size, and then combined effects in a random-effects meta-analysis. We assessed the impact of study design factors and reporting of measures to reduce risks of bias. We present power analyses for the most frequently reported behavioural tests; 337 publications were included. Most studies (84%) used male animals only. The most frequently reported outcome measure was evoked limb withdrawal in response to mechanical monofilaments. There was modest reporting of measures to reduce risks of bias. The number of animals required to obtain 80% power with a significance level of 0.05 varied substantially across behavioural tests. In this comprehensive summary of the use of animal models of CIPN, we have identified areas in which the value of preclinical CIPN studies might be increased. Using both sexes of animals in the modelling of CIPN, ensuring that outcome measures align with those most relevant in the clinic, and the animal’s pain contextualised ethology will likely improve external validity. Measures to reduce risk of bias should be employed to increase the internal validity of studies. Different outcome measures have different statistical power, and this can refine our approaches in the modelling of CIPN. Many frequently used and effective cancer chemotherapies can cause a disabling side effect that features pain, numbness, tingling, and sensitivity to cold and heat in the extremities known as chemotherapy-induced peripheral neuropathy (CIPN). There are currently no effective therapies to treat or prevent this condition, and animal models have been developed to address this. It is important that experiments using animal models of CIPN are robust and valid if they are to effectively help patients. We used a systematic approach to identify all 337 studies that have been published describing the use of animal models of CIPN. We were able to identify that many studies are imperfect in their experimental design, use only male animals, and assess outcomes with limited relevance to the human condition. Based on a meta-analysis, we provide guidance to the CIPN animal modelling community to guide future experiments that may improve their utility and validity.

23 March 2019 in BJU International
Verified
Journal Article
Open access
PDF file
MAMohammed Aldiwani
Mohammed Aldiwani
FGFanourios Georgiades
Fanourios Georgiades
IOIsmail Omar
Ismail Omar
HAHelena Angel‐Scott
Helena Angel‐Scott
TTTharu Tharakan
Tharu Tharakan
EMErik Mayer
Erik Mayer
Objectives: To analyse the contemporary management of renal injuries in a UK major trauma centre and to evaluate the utility and value of re‐imaging. Patients and methods: The prospectively maintained ‘Trauma Audit and Research Network’ database was interrogated to identify patients with urinary tract injuries between January 2014 and December 2017. Patients’ records and imaging were reviewed to identify injury grades, interventions, outcomes, and follow‐up. Results: Renal injury was identified in 90 patients (79 males and 11 females). The mean ( sd ; range) age was 35.5 (17.4; 1.5–94) years. Most of the renal traumas were caused by blunt mechanisms (74%). The overall severity of injuries was: 18 (20%) Grade I, 19 (21%) Grade II, 27 (30%) Grade III, 22 (24%) Grade IV, and four (4%) Grade V. Most patients (84%) were managed conservatively. Early intervention (<24 h) was performed in 14 patients (16%) for renal injuries. Most of these patients were managed by interventional radiology techniques (nine of 14). Only two patients required an emergency nephrectomy, both of whom died from extensive polytrauma. In all, 19 patients underwent laparotomy for other injuries and did not require renal exploration. The overall 30‐day mortality was 13%. Re‐imaging was performed in 66% of patients at an average time of 3.4 days from initial scan. The majority of re‐imaging was planned (49 patients) and 12% of these scans demonstrated a relevant finding (urinoma, pseudoaneurysm) that altered management in three of the 49 patients (6.1%). Conclusion: Non‐operative management is the mainstay for all grades of injury. Haemodynamic instability and persistent urine leak are primary indications for intervention. Open surgical management is uncommon. Repeat imaging after injury is advocated for stable patients with high‐grade renal injuries (Grade III–V), although more research is needed to determine the optimal timing.

19 November 2025 in eClinicalMedicine
Verified
Journal Article
Open access
HAHelena Angel-Scott
Helena Angel-Scott
ABAshna Basu
Ashna Basu
ATAllyson Tai
Allyson Tai
PGPramudie Gunaratne
Pramudie Gunaratne
PBPatrick Bolton
Patrick Bolton
MLMatthew Large
Matthew Large
Mortality in psychiatric hospitals is both elevated and poorly understood. We aimed to address a knowledge gap about cause-specific mortality among current psychiatric inpatients using a meta-analytic synthesis of primary research reporting on the natural, unnatural, and cause-specific mortalities. We conducted a systematic review and meta-analysis according to PRISMA and MOOSE guidelines. Searches for peer reviewed English language papers published between 1 January 1960 and 24 July 2025 and indexed in MEDLINE, PsycINFO, EMBASE and PubMed were supplemented using searches of grey literature and hand searches of reference lists. Data were pooled using random effects meta-analysis. Mortalities were assessed by cause-specific estimates of. i) the percentage of deaths, ii) mortality per 10,000 admissions and iii) mortality rates per 100,000 person-years. Temporal trends were examined using mixed effects meta-regression. A mixed effects model was used to examine subgroups within each mortality according to publication date and the national income of the study setting. This study is registered with PROSPERO (CRD42024572461). Thirty-eight studies published from diverse geographic settings over the last five decades were included in a meta-analysis of the percentage of mortality according to cause. Of these, twenty-eight studies were included in a meta-analysis of the mortality per 10,000 admissions and twenty-five studies were included in a meta-analysis of mortality rates per 100,000 patient-years. Natural causes accounted for 81.6% (95% confidence interval (CI) 75.7–86.3%, I-square = 98.5) of inpatient deaths. Vascular causes accounted for 31.0% (95% CI, 27.0–35.2%) of deaths, and infection accounted for 17.8% (CI 11.8–26.0%), The pooled estimate of natural deaths per 10,000 admissions was 78.9 (95% CI, 43.1–143.9, I-square = 99.8), falling from 246.6 (95% CI, 132.9–453.1) in pre-2000 studies to 35.2 (95% CI, 18.8–65.8) in more recent studies. The pooled estimate of the natural mortality rate per 100,000 patient-years was 2905.0 (95% CI, 2350.8–3459.2, I-square = 99.4), with rates falling from 5445.4 (95% CI, 4460.9–6429.9) in pre-2000 studies to 1374.3 (95% CI, 968.3–1780.2) in more recent studies. Suicides and accidents respectively accounted for 4.8% (95% CI, 3.0–7.7%) and 3.3% (2.3–4.7%) of deaths. Unnatural mortality rates have been stable over time. All mortality measures had high between study heterogeneity that was not well explained by the available moderators of year of publication and national income of the study setting. Mortality rates in psychiatric hospitals are highly heterogeneous but have been falling over time. Most inpatient deaths have a natural cause. Our findings suggest a need for primary research examining the demographic and diagnostic associations with inpatient mortality, while underscoring the opportunities for better integration of medical and mental health care. None.